ensembl_id string | gene string | gene_description string | uniprot list | chromosome string | position string | evidence string | hpa_evidence string | uniprot_evidence string | nextprot_evidence string | antibodies list | gene_synonyms list | protein_classes list | biological_processes list | molecular_functions list | disease_involvement list | subcellular_main_locations list | subcellular_additional_locations list | secretome_locations list | secretome_functions list | reliability_if string | reliability_ih string | reliability_mouse_brain string | interactions float64 | ccd_protein string | ccd_transcript string | blood_expression_cluster string | brain_expression_cluster string | cell_line_expression_cluster string | single_cell_expression_cluster string | tissue_expression_cluster string | rna_tissue_specificity string | rna_tissue_distribution string | rna_tissue_specificity_score float64 | rna_cell_line_specificity string | rna_cell_line_distribution string | rna_cell_line_specificity_score float64 | rna_cancer_specificity string | rna_cancer_distribution string | rna_cancer_specificity_score float64 | rna_single_cell_type_specificity string | rna_single_cell_type_distribution string | rna_single_cell_type_specificity_score float64 | rna_blood_cell_specificity string | rna_blood_cell_distribution string | rna_blood_cell_specificity_score float64 | prognostic_cancer_count int64 | validated_prognostic_cancer_count int64 | potential_prognostic_cancer_count int64 | favorable_prognostic_cancers list | unfavorable_prognostic_cancers list | prognostic_cancers list | source_row_index int64 | split_bucket int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ENSG00000024422 | EHD2 | EH domain containing 2 | [
"Q9NZN4"
] | 19 | 47713422-47743134 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA047394",
"HPA049890",
"HPA049986",
"HPA066751"
] | [
"PAST2"
] | [
"Predicted intracellular proteins"
] | [] | [
"Hydrolase"
] | [] | [
"Plasma membrane"
] | [
"Primary cilium",
"Primary cilium transition zone"
] | [] | [] | Supported | Approved | null | 4 | null | null | null | Cluster 19: Astrocytes - Mixed function | Cluster 64: Connective tissue cells - ECM organization | Cluster 110: Mural cells - ECM organization | Cluster 12: Smooth muscle tissue - ECM organization | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Glioblastoma Multiforme"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | 436 | 3 |
ENSG00000024526 | DEPDC1 | DEP domain containing 1 | [
"Q5TB30"
] | 1 | 68474152-68497221 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB017845"
] | [
"DEP.8",
"DEPDC1A",
"FLJ20354",
"SDP35"
] | [
"Predicted intracellular proteins"
] | [
"Transcription",
"Transcription regulation"
] | [
"GTPase activation",
"Repressor"
] | [] | [
"Nucleoplasm"
] | [
"Nucleoli fibrillar center"
] | [] | [] | Supported | Approved | null | 2 | null | Yes | null | null | Cluster 37: Non-specific - mRNA processing | Cluster 27: Non-specific - Cell proliferation | Cluster 59: Lymphoid tissue & Bone marrow - Cell proliferation | Tissue enhanced | Detected in some | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 5 | 4 | 3 | [] | [
"Bladder Urothelial Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Bladder Urothelial Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 437 | 9 |
ENSG00000024862 | CCDC28A | Coiled-coil domain containing 28A | [] | 6 | 138773769-138793319 | Evidence at transcript level | Evidence at transcript level | null | null | [
"HPA055125"
] | [
"C6orf80",
"CCRL1AP",
"DKFZp586D0623"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Plasma membrane"
] | [
"Nucleoplasm"
] | [] | [] | Approved | Approved | null | null | null | null | Cluster 35: Neutrophils - Protein binding | Cluster 23: Choroid plexus - Mixed function | Cluster 28: Non-specific - Nuclear processes | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 1: Choroid plexus - Transmembrane transport | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 438 | 6 |
ENSG00000025039 | RRAGD | Ras related GTP binding D | [
"Q9NQL2"
] | 6 | 89364616-89412273 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA068664"
] | [
"bA11D8.2.1",
"DKFZP761H171"
] | [
"Human disease related genes",
"Predicted intracellular proteins"
] | [] | [
"Hydrolase"
] | [
"Cardiomyopathy",
"Disease variant",
"Primary hypomagnesemia"
] | [
"Nucleoplasm"
] | [
"Vesicles",
"Centrosome"
] | [] | [] | Approved | Approved | null | 23 | null | null | Cluster 35: Neutrophils - Protein binding | Cluster 31: Non-specific - Transcription | Cluster 51: Myeloma - Immunoglobulins | Cluster 72: Macrophages - Phagocytosis & lysosomal degradation | Cluster 62: Skeletal muscle - Muscle contraction | Tissue enhanced | Detected in all | null | Cancer enhanced | Detected in many | null | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in some | null | 3 | 2 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Stomach Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Stomach Adenocarcinoma"
] | 439 | 7 |
ENSG00000025156 | HSF2 | Heat shock transcription factor 2 | [
"Q03933"
] | 6 | 122399551-122433119 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB016067",
"HPA031455"
] | [] | [
"Plasma proteins",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Stress response",
"Transcription",
"Transcription regulation"
] | [
"Activator",
"DNA-binding"
] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Approved | null | 27 | No | No | Cluster 43: Non-specific - Transcription & Translation | Cluster 31: Non-specific - Transcription | Cluster 5: Rhabdoid - Unknown function | Cluster 36: Skeletal myocytes - Muscle excitation & contraction | Cluster 40: Non-specific - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 3 | 2 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 440 | 1 |
ENSG00000025293 | PHF20 | PHD finger protein 20 | [
"Q9BVI0"
] | 20 | 35771974-35950370 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA029619",
"HPA029620",
"HPA029621"
] | [
"C20orf104",
"dJ1121G12.1",
"TDRD20A"
] | [
"Cancer-related genes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Transcription",
"Transcription regulation"
] | [
"Chromatin regulator",
"DNA-binding"
] | [
"Cancer-related genes"
] | [
"Nucleoplasm"
] | [
"Nuclear membrane",
"Golgi apparatus",
"Cytosol"
] | [] | [] | Supported | Approved | null | 38 | null | null | Cluster 45: Eosinophils - Unknown function | Cluster 55: Non-specific - Transcription | Cluster 62: Non-specific - Plasma proteins | Cluster 31: Neutrophils - Chemotaxis & Apoptosis | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Chromophobe",
"Ovary Serous Cystadenocarcinoma"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | 441 | 1 |
ENSG00000025423 | HSD17B6 | Hydroxysteroid 17-beta dehydrogenase 6 | [
"O14756"
] | 12 | 56752161-56787790 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA059141"
] | [
"HSE",
"RODH",
"SDR9C6"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [
"Lipid metabolism",
"Steroid metabolism"
] | [
"Oxidoreductase"
] | [] | [
"Nucleoplasm",
"Vesicles"
] | [] | [] | [] | Approved | Enhanced | null | null | null | null | Cluster 13: Non-specific - Mitochondria | Cluster 40: Astrocytes - Astrocyte-neuron interactions | Cluster 64: Connective tissue cells - ECM organization | Cluster 93: Hepatocytes - Bile production & excretion | Cluster 45: Liver - Metabolism & Coagulation | Tissue enriched | Detected in many | 26 | Low cancer specificity | Detected in many | null | Cancer enriched | Detected in many | 5 | Cell type enriched | Detected in many | 9 | Low immune cell specificity | Detected in some | null | 1 | 2 | 0 | [
"Liver Hepatocellular Carcinoma"
] | [] | [
"Liver Hepatocellular Carcinoma"
] | 442 | 1 |
ENSG00000025434 | NR1H3 | Nuclear receptor subfamily 1 group H member 3 | [
"Q13133"
] | 11 | 47248300-47269033 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA036443",
"CAB037109"
] | [
"LXR-a",
"LXRa",
"RLD-1"
] | [
"Nuclear receptors",
"Plasma proteins",
"Predicted intracellular proteins",
"Transcription factors",
"Transporters"
] | [
"Transcription",
"Transcription regulation"
] | [
"Activator",
"DNA-binding",
"Receptor"
] | [] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Approved | Approved | null | 29 | null | null | Cluster 37: Monocytes & Neutrophils - Innate immune response | Cluster 19: Astrocytes - Mixed function | Cluster 57: Stomach & Colon cancer - Digestion | Cluster 72: Macrophages - Phagocytosis & lysosomal degradation | Cluster 28: Liver & Adrenal gland - Secretion | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 0 | 0 | 0 | [] | [] | [] | 443 | 6 |
ENSG00000025708 | TYMP | Thymidine phosphorylase | [
"P19971"
] | 22 | 50525752-50530032 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA000530",
"HPA001072",
"CAB002518"
] | [
"ECGF1",
"MNGIE"
] | [
"Cancer-related genes",
"Disease related genes",
"Enzymes",
"FDA approved drug targets",
"Human disease related genes",
"Metabolic proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Angiogenesis",
"Chemotaxis",
"Differentiation"
] | [
"Developmental protein",
"Glycosyltransferase",
"Growth factor",
"Transferase"
] | [
"Cancer-related genes",
"Disease variant",
"FDA approved drug targets",
"Neuropathy",
"Primary mitochondrial disease",
"Progressive external ophthalmoplegia"
] | [
"Nuclear bodies",
"Golgi apparatus"
] | [
"Cytosol"
] | [] | [] | Approved | Enhanced | null | 24 | null | null | Cluster 25: Non-specific - Unknown function | Cluster 20: Macrophages & Microglia - Immune response | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 40: Monocytes & Neutrophils - Inflammatory signaling | Cluster 5: Spleen - Immune response | Low tissue specificity | Detected in many | null | Cancer enhanced | Detected in many | null | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in all | 5 | 0 | 0 | 0 | [] | [] | [] | 444 | 6 |
ENSG00000025770 | NCAPH2 | Non-SMC condensin II complex subunit H2 | [
"Q6IBW4"
] | 22 | 50508224-50524780 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA067932",
"HPA069056"
] | [
"384D8-2",
"CAP-H2",
"hCAP-H2"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [
"DNA condensation"
] | [] | [] | [
"Nucleoplasm"
] | [
"Cell Junctions",
"Cytokinetic bridge"
] | [] | [] | Supported | Enhanced | null | 15 | Yes | No | Cluster 42: Non-specific - Vesicular transport | Cluster 34: Non-specific - Mixed function | Cluster 66: Non-specific - Mitochondria | Cluster 27: Non-specific - Cell proliferation | Cluster 68: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 2 | 2 | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 445 | 9 |
ENSG00000025772 | TOMM34 | Translocase of outer mitochondrial membrane 34 | [
"Q15785"
] | 20 | 44942130-44960397 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA018845",
"HPA056875"
] | [
"HTOM34P",
"TOM34"
] | [
"Predicted intracellular proteins"
] | [] | [
"Chaperone"
] | [] | [
"Cytosol"
] | [
"Vesicles",
"Mitochondria"
] | [] | [] | Supported | Enhanced | null | 32 | null | null | Cluster 23: B-cells - Immunoglobulins | Cluster 51: Neurons - Mixed function | Cluster 62: Non-specific - Plasma proteins | Cluster 63: Cytotrophoblasts - Basic cellular functions | Cluster 56: Ciliated tissues - Cilium organization | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 2 | 1 | [] | [
"Head and Neck Squamous Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 446 | 4 |
ENSG00000025796 | SEC63 | SEC63 homolog, protein translocation regulator | [
"Q9UGP8"
] | 6 | 107867756-107958208 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA053295",
"HPA060535"
] | [
"DNAJC23",
"ERdj2",
"PRO2507",
"SEC63L"
] | [
"Disease related genes",
"Essential proteins",
"Human disease related genes",
"Potential drug targets",
"Predicted membrane proteins",
"Transporters"
] | [
"Protein transport",
"Transport"
] | [
"Chaperone"
] | [
"Disease variant"
] | [
"Endoplasmic reticulum"
] | [] | [] | [] | Supported | Supported | null | 69 | null | null | Cluster 45: Eosinophils - Unknown function | Cluster 50: Non-specific - Nucleic acid binding | Cluster 28: Non-specific - Nuclear processes | Cluster 37: Neutrophil progenitors - Granulopoiesis | Cluster 38: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Chromophobe"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma"
] | 447 | 4 |
ENSG00000025800 | KPNA6 | Karyopherin subunit alpha 6 | [
"O60684"
] | 1 | 32108056-32176563 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA018863"
] | [
"FLJ11249",
"IPOA7",
"KPNA7",
"MGC17918"
] | [
"Metabolic proteins",
"Plasma proteins",
"Predicted intracellular proteins",
"Transporters"
] | [
"Host-virus interaction",
"Protein transport",
"Transport"
] | [] | [] | [
"Cytosol"
] | [
"Nucleoplasm"
] | [] | [] | Approved | Supported | null | 96 | null | null | Cluster 13: Non-specific - Mitochondria | Cluster 45: Non-specific - Mixed function | Cluster 37: Non-specific - mRNA processing | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 25: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 448 | 7 |
ENSG00000026025 | VIM | Vimentin | [
"P08670"
] | 10 | 17228241-17237593 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB000080",
"HPA001762",
"CAB058687"
] | [] | [
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Host-virus interaction"
] | [] | [
"Cataract",
"Disease variant"
] | [
"Intermediate filaments"
] | [] | [] | [] | Supported | Enhanced | null | 272 | null | null | Cluster 26: Monocytes - Plasma membrane proteins | Cluster 12: Non-specific - Vasculature | Cluster 72: Neuronal - Signal transduction | Cluster 97: Non-specific - Cellular respiration | Cluster 12: Smooth muscle tissue - ECM organization | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 0 | 0 | 0 | [] | [] | [] | 449 | 7 |
ENSG00000026103 | FAS | Fas cell surface death receptor | [
"P25445"
] | 10 | 88953813-89029605 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA027444"
] | [
"APO-1",
"APT1",
"CD95",
"FAS1",
"TNFRSF6"
] | [
"Cancer-related genes",
"Candidate cardiovascular disease genes",
"CD markers",
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Predicted secreted proteins"
] | [
"Apoptosis"
] | [
"Calmodulin-binding",
"Receptor"
] | [
"Cancer-related genes",
"Disease variant"
] | [
"Plasma membrane"
] | [
"Nuclear bodies",
"Cytosol"
] | [
"Secreted to blood"
] | [
"Receptor"
] | Supported | Uncertain | null | 34 | null | null | Cluster 35: Neutrophils - Protein binding | Cluster 48: Non-specific - Mixed function | Cluster 12: Bone cancer - Neuronal signaling | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 49: Non-specific - Transcription | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Glioblastoma Multiforme",
"Pancreatic Adenocarcinoma"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 450 | 6 |
ENSG00000026297 | RNASET2 | Ribonuclease T2 | [
"O00584"
] | 6 | 166922113-166957191 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA029013",
"HPA066509"
] | [
"bA514O12.3",
"FLJ10907",
"RNASE6PL"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Potential drug targets",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [
"Immunity",
"Innate immunity"
] | [
"Endonuclease",
"Hydrolase",
"Lyase",
"Nuclease"
] | [
"Disease variant"
] | [] | [] | [
"Secreted to blood"
] | [
"Immunity"
] | null | Approved | null | 4 | null | null | Cluster 25: Non-specific - Unknown function | Cluster 20: Macrophages & Microglia - Immune response | Cluster 15: Kidney cancer - Membrane components | Cluster 52: Glandular & Luminal cells - Estrogen-regulated epithelial secretion | Cluster 22: Epididymis - Mixed function | Low tissue specificity | Detected in all | null | Cancer enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Colon Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Colon Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 451 | 5 |
ENSG00000026508 | CD44 | CD44 molecule (Indian blood group) | [
"P16070"
] | 11 | 35138882-35232402 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB000112",
"CAB000316",
"HPA005785"
] | [
"CD44R",
"CSPG8",
"HCELL",
"IN",
"MC56",
"MDU2",
"MDU3",
"MIC4",
"Pgp1"
] | [
"Blood group antigen proteins",
"Cancer-related genes",
"CD markers",
"FDA approved drug targets",
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Predicted secreted proteins",
"Transporters"
] | [
"Cell adhesion"
] | [
"Blood group antigen",
"Receptor"
] | [
"Cancer-related genes",
"FDA approved drug targets"
] | [
"Plasma membrane"
] | [
"Golgi apparatus"
] | [
"Secreted to blood"
] | [
"Receptor"
] | Supported | Enhanced | null | 27 | null | null | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 39: Astrocytes - Mixed function | Cluster 72: Neuronal - Signal transduction | Cluster 40: Monocytes & Neutrophils - Inflammatory signaling | Cluster 58: Skin - Keratinization | Tissue enhanced | Detected in all | null | Cancer enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | 452 | 9 |
ENSG00000026559 | KCNG1 | Potassium voltage-gated channel modifier subfamily G member 1 | [
"Q9UIX4"
] | 20 | 51003656-51023107 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA039530",
"HPA040024"
] | [
"K13",
"KCNG",
"kH2",
"Kv6.1"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Transporters",
"Voltage-gated ion channels"
] | [
"Ion transport",
"Potassium transport",
"Transport"
] | [
"Ion channel",
"Potassium channel",
"Voltage-gated channel"
] | [] | [
"Vesicles"
] | [] | [] | [] | Approved | Approved | null | null | null | null | Cluster 34: B-cells - Unknown function | Cluster 14: Neurons - Synaptic function | Cluster 72: Neuronal - Signal transduction | Cluster 63: Cytotrophoblasts - Basic cellular functions | Cluster 75: Ovary - Mixed function | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cancer enriched | Detected in many | 4 | Cell type enhanced | Detected in many | null | Immune cell enriched | Detected in single | 18 | 2 | 0 | 2 | [] | [
"Head and Neck Squamous Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 453 | 4 |
ENSG00000026652 | AGPAT4 | 1-acylglycerol-3-phosphate O-acyltransferase 4 | [
"Q9NRZ5"
] | 6 | 161129967-161274061 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA053287",
"HPA060525"
] | [
"dJ473J16.2",
"LPAAT-delta",
"LPAAT4",
"LPLAT4"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Lipid biosynthesis",
"Lipid metabolism",
"Phospholipid biosynthesis",
"Phospholipid metabolism"
] | [
"Acyltransferase",
"Transferase"
] | [] | [
"Golgi apparatus"
] | [
"Nucleoli",
"Vesicles"
] | [] | [] | Approved | Approved | null | 28 | null | null | Cluster 15: NK-cells - Unknown function | Cluster 30: White matter - Myelination | Cluster 72: Neuronal - Signal transduction | Cluster 40: Monocytes & Neutrophils - Inflammatory signaling | Cluster 3: Oligodendrocytes - Myelination | Tissue enriched | Detected in many | 5 | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 2 | 0 | 2 | [] | [
"Bladder Urothelial Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Bladder Urothelial Carcinoma",
"Pancreatic Adenocarcinoma"
] | 454 | 3 |
ENSG00000026751 | SLAMF7 | SLAM family member 7 | [
"Q9NQ25"
] | 1 | 160739057-160754821 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB015445",
"HPA055945",
"HPA061654"
] | [
"19A",
"CD319",
"CRACC",
"CS1"
] | [
"CD markers",
"FDA approved drug targets",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Adaptive immunity",
"Immunity",
"Innate immunity"
] | [
"Receptor"
] | [
"FDA approved drug targets"
] | [
"Vesicles"
] | [] | [] | [] | Approved | Enhanced | null | null | null | null | Cluster 8: Plasmacytoid DCs - Unknown function | Cluster 8: Immune cells - Immune response | Cluster 51: Myeloma - Immunoglobulins | Cluster 44: Plasma cells - Antibody production & secretion | Cluster 34: Lymphoid tissue - Adaptive immune response | Tissue enhanced | Detected in many | null | Cancer enriched | Detected in many | 5 | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in some | null | Low immune cell specificity | Detected in many | null | 1 | 0 | 1 | [
"Ovary Serous Cystadenocarcinoma"
] | [] | [
"Ovary Serous Cystadenocarcinoma"
] | 455 | 9 |
ENSG00000026950 | BTN3A1 | Butyrophilin subfamily 3 member A1 | [
"O00481"
] | 6 | 26402237-26415208 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA012565"
] | [
"BT3.1",
"BTF5",
"BTN3.1",
"CD277"
] | [
"CD markers",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Adaptive immunity",
"Immunity"
] | [] | [] | [
"Vesicles"
] | [] | [] | [] | Uncertain | Approved | null | 10 | null | null | Cluster 1: T-cells - Unknown function | Cluster 43: Hindbrain - Mixed function | Cluster 31: Non-specific - Antiviral immune response | Cluster 92: NK-cells & T-cells - Adaptive immunity: Cytotoxicity | Cluster 66: Lymphoid tissue - Immune response | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Liver Hepatocellular Carcinoma"
] | [] | [
"Liver Hepatocellular Carcinoma"
] | 456 | 9 |
ENSG00000027001 | MIPEP | Mitochondrial intermediate peptidase | [
"Q99797"
] | 13 | 23730189-23889400 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA030676",
"HPA031669",
"HPA031670"
] | [
"MIP"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Plasma proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [] | [
"Hydrolase",
"Metalloprotease",
"Protease"
] | [
"Disease variant",
"Primary mitochondrial disease"
] | [
"Mitochondria"
] | [] | [] | [] | Enhanced | Approved | null | 13 | null | null | Cluster 14: Non-specific - Unknown function | Cluster 29: Forebrain - Mixed function | Cluster 19: Non-specific - Unknown function | Cluster 34: Ciliated cells - Cilia assembly & function | Cluster 76: Non-specific - Metabolism | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | 457 | 2 |
ENSG00000027075 | PRKCH | Protein kinase C eta | [
"P24723"
] | 14 | 61187559-61550976 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA026294",
"HPA053709"
] | [
"PKC-L",
"PKCL",
"PRKCL"
] | [
"Cancer-related genes",
"Disease related genes",
"Enzymes",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Differentiation"
] | [
"Kinase",
"Serine/threonine-protein kinase",
"Transferase"
] | [
"Cancer-related genes"
] | [
"Cytosol"
] | [
"Plasma membrane"
] | [] | [] | Approved | Approved | null | null | null | null | Cluster 27: T-cells - Unknown function | Cluster 38: Sub-cortical - Mixed function | Cluster 59: Leukemia - T-cell receptor | Cluster 92: NK-cells & T-cells - Adaptive immunity: Cytotoxicity | Cluster 66: Lymphoid tissue - Immune response | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in many | 11 | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 458 | 7 |
ENSG00000027644 | INSRR | Insulin receptor related receptor | [
"P14616"
] | 1 | 156840063-156859117 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA025285"
] | [
"IRR"
] | [
"Enzymes",
"Predicted membrane proteins"
] | [] | [
"Kinase",
"Receptor",
"Transferase",
"Tyrosine-protein kinase"
] | [] | [] | [] | [] | [] | null | Uncertain | null | 33 | null | null | null | Cluster 49: Hindbrain - Mixed function | Cluster 11: Neuronal - Sensory perception | Cluster 86: Retinal bipolar cells - Synaptic signal transduction | Cluster 72: Kidney - Transmembrane transport | Tissue enhanced | Detected in some | null | Cancer enriched | Detected in single | 8 | Cancer enhanced | Detected in single | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 459 | 8 |
ENSG00000027697 | IFNGR1 | Interferon gamma receptor 1 | [
"P15260"
] | 6 | 137197483-137219449 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB025889",
"HPA029213",
"HPA063871",
"CAB080493",
"CAB080494",
"CAB080495"
] | [
"CD119",
"IFNGR"
] | [
"CD markers",
"Disease related genes",
"FDA approved drug targets",
"Human disease related genes",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [
"Receptor"
] | [
"Disease variant",
"FDA approved drug targets"
] | [
"Plasma membrane"
] | [] | [] | [] | Supported | Supported | null | 24 | null | null | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 30: White matter - Myelination | Cluster 71: Lymphoma - Inflammatory response | Cluster 40: Monocytes & Neutrophils - Inflammatory signaling | Cluster 66: Lymphoid tissue - Immune response | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 460 | 3 |
ENSG00000027847 | B4GALT7 | Beta-1,4-galactosyltransferase 7 | [
"Q9UBV7"
] | 5 | 177600132-177610330 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA042330"
] | [
"beta4Gal-T7",
"XGALT-1"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [] | [
"Glycosyltransferase",
"Transferase"
] | [
"Disease variant",
"Dwarfism",
"Ehlers-Danlos syndrome"
] | [] | [] | [] | [] | null | Supported | null | 8 | null | null | Cluster 29: Non-specific - Unknown function | Cluster 41: Monoamines - Neurotransmitter signalling | Cluster 22: Non-specific - mRNA splicing & Cell cycle | Cluster 21: Extravillous trophoblasts - Placental invasion & endocrine regulatio | Cluster 70: Non-specific - Protein processing | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 461 | 4 |
ENSG00000027869 | SH2D2A | SH2 domain containing 2A | [
"Q9NP31"
] | 1 | 156806243-156816848 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA074482"
] | [
"F2771",
"TSAd"
] | [
"Predicted intracellular proteins"
] | [
"Angiogenesis",
"Differentiation"
] | [
"Developmental protein"
] | [] | [] | [] | [] | [] | null | Enhanced | null | 43 | null | null | Cluster 1: T-cells - Unknown function | Cluster 47: Endothelial cells - Vasculature | Cluster 71: Lymphoma - Inflammatory response | Cluster 92: NK-cells & T-cells - Adaptive immunity: Cytotoxicity | Cluster 66: Lymphoid tissue - Immune response | Tissue enhanced | Detected in many | null | Group enriched | Detected in many | 6 | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in some | null | Low immune cell specificity | Detected in many | null | 3 | 0 | 3 | [
"Breast Invasive Carcinoma"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | 462 | 3 |
ENSG00000028116 | VRK2 | VRK serine/threonine kinase 2 | [
"Q86Y07"
] | 2 | 57907629-58159920 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB046459",
"HPA047503"
] | [] | [
"Enzymes",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Host-virus interaction"
] | [
"Kinase",
"Serine/threonine-protein kinase",
"Transferase"
] | [] | [
"Endoplasmic reticulum"
] | [] | [] | [] | Supported | Approved | null | 37 | null | null | Cluster 29: Non-specific - Unknown function | Cluster 11: White matter - Signal transduction | Cluster 26: Non-specific - Mitochondria & RNA binding | Cluster 80: Oligodendrocytes - Myelination | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 4 | 0 | 4 | [] | [
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 463 | 9 |
ENSG00000028137 | TNFRSF1B | TNF receptor superfamily member 1B | [
"P20333"
] | 1 | 12166991-12209228 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA004796"
] | [
"CD120b",
"p75",
"TNF-R-II",
"TNF-R75",
"TNFBR",
"TNFR2",
"TNFR80"
] | [
"Cancer-related genes",
"Candidate cardiovascular disease genes",
"CD markers",
"Human disease related genes",
"Plasma proteins",
"Predicted membrane proteins",
"Predicted secreted proteins"
] | [
"Apoptosis"
] | [
"Receptor"
] | [
"Cancer-related genes"
] | [] | [] | [
"Secreted to blood"
] | [
"Receptor"
] | null | Approved | null | 21 | null | null | Cluster 37: Monocytes & Neutrophils - Innate immune response | Cluster 12: Non-specific - Vasculature | Cluster 55: Lymphoma - Immune response | Cluster 40: Monocytes & Neutrophils - Inflammatory signaling | Cluster 66: Lymphoid tissue - Immune response | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 464 | 7 |
ENSG00000028203 | VEZT | Vezatin, adherens junctions transmembrane protein | [
"Q9HBM0"
] | 12 | 95217746-95302799 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA004811",
"HPA017066"
] | [
"DKFZP761C241"
] | [
"Essential proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Transporters"
] | [] | [] | [] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Supported | Approved | null | 9 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 2: Neurons - Nucleosome | Cluster 38: Non-specific - Transcription | Cluster 79: Photoreceptor cells - Phototransduction | Cluster 19: Skeletal muscle - Striated muscle contraction | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in many | null | 1 | 0 | 1 | [] | [
"Ovary Serous Cystadenocarcinoma"
] | [
"Ovary Serous Cystadenocarcinoma"
] | 465 | 8 |
ENSG00000028277 | POU2F2 | POU class 2 homeobox 2 | [
"P09086"
] | 19 | 42086110-42196585 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB002513",
"HPA049056",
"HPA062096",
"HPA064404",
"HPA073998"
] | [
"OCT2",
"OTF2"
] | [
"Cancer-related genes",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"Activator",
"DNA-binding"
] | [
"Cancer-related genes"
] | [
"Nucleoplasm",
"Vesicles"
] | [] | [] | [] | Enhanced | Enhanced | null | 10 | null | null | Cluster 40: Monocytes - Innate immune response | Cluster 10: Cerebellum - Nucleic acid binding | Cluster 55: Lymphoma - Immune response | Cluster 87: B-cells - Adaptive immunity: Humoral response | Cluster 18: Lymphoid tissue - Immune response | Tissue enriched | Detected in many | 5 | Group enriched | Detected in many | 4 | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 0 | 0 | 0 | [] | [] | [] | 466 | 5 |
ENSG00000028310 | BRD9 | Bromodomain containing 9 | [
"Q9H8M2"
] | 5 | 850291-892801 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA021465",
"HPA023197"
] | [
"FLJ13441",
"SMARCI2"
] | [
"Predicted intracellular proteins"
] | [
"Transcription",
"Transcription regulation"
] | [
"Chromatin regulator"
] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Enhanced | Uncertain | null | 28 | null | null | Cluster 45: Eosinophils - Unknown function | Cluster 13: Oligodendrocytes - Mixed function | Cluster 29: Non-specific - Unknown function | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 68: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Glioblastoma Multiforme"
] | [
"Bladder Urothelial Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Bladder Urothelial Carcinoma",
"Glioblastoma Multiforme",
"Liver Hepatocellular Carcinoma"
] | 467 | 2 |
ENSG00000028528 | SNX1 | Sorting nexin 1 | [
"Q13596"
] | 15 | 64094123-64146090 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA047373",
"HPA052761"
] | [
"HsT17379",
"MGC8664",
"SNX1A",
"Vps5"
] | [
"Predicted intracellular proteins",
"Transporters"
] | [
"Protein transport",
"Transport"
] | [] | [] | [
"Endosomes",
"Lysosomes"
] | [] | [] | [] | Enhanced | Approved | null | 65 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 30: White matter - Myelination | Cluster 58: Non-specific - Nuclear processes | Cluster 36: Skeletal myocytes - Muscle excitation & contraction | Cluster 11: Esophagus - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 1 | 2 | 0 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 468 | 4 |
ENSG00000028839 | TBPL1 | TATA-box binding protein like 1 | [
"P62380"
] | 6 | 133952170-133990432 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA071810",
"HPA071813"
] | [
"STUD",
"TLF",
"TLP",
"TRF2"
] | [
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"DNA-binding"
] | [] | [
"Nucleoplasm"
] | [
"Nucleoli"
] | [] | [] | Supported | Enhanced | null | 16 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 14: Neurons - Synaptic function | Cluster 47: Leukemia - Hemostasis | Cluster 53: Late primary spermatocytes - Meiotic division & transition | Cluster 39: Testis - Nuclear processes | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 2 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 469 | 6 |
ENSG00000029153 | BMAL2 | Basic helix-loop-helix ARNT like 2 | [
"Q8WYA1"
] | 12 | 27332836-27425289 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA059074"
] | [
"ARNTL2",
"bHLHe6",
"CLIF",
"MOP9",
"PASD9"
] | [
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Biological rhythms",
"Transcription",
"Transcription regulation"
] | [
"Activator",
"DNA-binding"
] | [] | [
"Nucleoplasm",
"Nucleoli"
] | [] | [] | [] | Supported | Uncertain | null | 4 | No | No | null | Cluster 40: Astrocytes - Astrocyte-neuron interactions | Cluster 72: Neuronal - Signal transduction | Cluster 49: Apical squamous epithelium - Epithelial barrier & keratinization | Cluster 81: Squamous epithelium - Keratinization | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in single | null | 2 | 4 | 0 | [] | [
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 470 | 6 |
ENSG00000029363 | BCLAF1 | BCL2 associated transcription factor 1 | [
"Q9NYF8"
] | 6 | 136256627-136289851 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA006484",
"HPA006669",
"HPA027770"
] | [
"BTF",
"KIAA0164"
] | [
"Cancer-related genes",
"Essential proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Transcription",
"Transcription regulation"
] | [
"DNA-binding",
"Repressor"
] | [
"Cancer-related genes"
] | [
"Nuclear speckles"
] | [] | [] | [] | Enhanced | Enhanced | null | 62 | null | null | Cluster 35: Neutrophils - Protein binding | Cluster 31: Non-specific - Transcription | Cluster 28: Non-specific - Nuclear processes | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 44: Bone marrow - Nuclear processes | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Breast Invasive Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 471 | 7 |
ENSG00000029364 | SLC39A9 | Solute carrier family 39 member 9 | [
"Q9NUM3"
] | 14 | 69398015-69462390 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA007921",
"HPA075390"
] | [
"FLJ11274"
] | [
"Predicted membrane proteins",
"Transporters"
] | [
"Ion transport",
"Transport",
"Zinc transport"
] | [] | [] | [
"Endoplasmic reticulum"
] | [] | [] | [] | Approved | Approved | null | 38 | null | null | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 21: Non-specific - Metabolism | Cluster 30: Non-specific - Gene expression regulation | Cluster 8: Non-specific - Secretory pathway | Cluster 38: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 472 | 1 |
ENSG00000029534 | ANK1 | Ankyrin 1 | [
"P16157"
] | 8 | 41653220-41896741 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA004842",
"HPA056953"
] | [
"ANK",
"SPH1"
] | [
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Potential drug targets",
"Predicted intracellular proteins",
"Transporters"
] | [] | [] | [
"Disease variant",
"Elliptocytosis",
"Hereditary hemolytic anemia"
] | [] | [] | [] | [] | null | Supported | Supported | 7 | null | null | Cluster 23: B-cells - Immunoglobulins | Cluster 26: Oligodendrocytes - Mixed function | Cluster 47: Leukemia - Hemostasis | Cluster 66: Erythroid cells - Erythroid differentiation and maturation | Cluster 30: Skeletal muscle - Striated muscle contraction | Group enriched | Detected in many | 8 | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in some | null | 1 | 0 | 1 | [] | [
"Glioblastoma Multiforme"
] | [
"Glioblastoma Multiforme"
] | 473 | 9 |
ENSG00000029559 | IBSP | Integrin binding sialoprotein | [
"P21815"
] | 4 | 87799554-87812435 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA059068",
"HPA065857"
] | [
"BSP",
"BSP-II",
"SP-II"
] | [
"Cancer-related genes",
"Predicted secreted proteins"
] | [
"Biomineralization",
"Cell adhesion"
] | [] | [
"Cancer-related genes"
] | [
"Vesicles"
] | [
"Nucleoplasm",
"Cytosol"
] | [
"Secreted in other tissues"
] | [
"Cell adhesion"
] | Approved | null | null | 1 | null | null | null | Cluster 12: Non-specific - Vasculature | Cluster 71: Lymphoma - Inflammatory response | Cluster 109: Neurons - Neuronal signaling | Cluster 74: Non-specific - Signal transduction | Tissue enhanced | Detected in some | null | Cancer enhanced | Detected in single | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | 474 | 9 |
ENSG00000029639 | TFB1M | Transcription factor B1, mitochondrial | [
"Q8WVM0"
] | 6 | 155256134-155314493 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA029428"
] | [
"CGI-75",
"mtTFB"
] | [
"Disease related genes",
"Predicted intracellular proteins"
] | [
"rRNA processing",
"Transcription",
"Transcription regulation"
] | [
"DNA-binding",
"Methyltransferase",
"RNA-binding",
"Transferase"
] | [] | [] | [] | [] | [] | null | Approved | null | 9 | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 53: Neurons - Mixed function | Cluster 28: Non-specific - Nuclear processes | Cluster 42: Early spermatids - Spermiogenesis: Acrosomal phase | Cluster 25: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Breast Invasive Carcinoma"
] | [
"Breast Invasive Carcinoma"
] | 475 | 7 |
ENSG00000029725 | RABEP1 | Rabaptin, RAB GTPase binding effector protein 1 | [
"Q15276"
] | 17 | 5282265-5386340 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB004549",
"HPA019669",
"HPA024235",
"HPA024691"
] | [
"neurocrescin",
"RAB5EP",
"rabaptin-5",
"RABPT5"
] | [
"Cancer-related genes",
"Predicted intracellular proteins"
] | [
"Apoptosis",
"Endocytosis",
"Protein transport",
"Transport"
] | [] | [
"Cancer-related genes"
] | [
"Vesicles",
"Cytosol"
] | [] | [] | [] | Supported | Supported | null | 79 | null | null | Cluster 14: Non-specific - Unknown function | Cluster 13: Oligodendrocytes - Mixed function | Cluster 42: Non-specific - Unknown function | Cluster 87: B-cells - Adaptive immunity: Humoral response | Cluster 25: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Chromophobe"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma"
] | 476 | 7 |
ENSG00000029993 | HMGB3 | High mobility group box 3 | [
"O15347"
] | X | 150980509-150990771 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA062583",
"HPA073663"
] | [
"HMG2A",
"HMG4",
"MGC90319"
] | [
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Immunity",
"Innate immunity",
"Transcription",
"Transcription regulation"
] | [
"DNA-binding"
] | [
"Microphthalmia"
] | [
"Nucleoplasm"
] | [
"Nucleoli"
] | [] | [] | Supported | Enhanced | null | 9 | null | null | Cluster 25: Non-specific - Unknown function | Cluster 4: Non-specific - mRNA splicing & Cell cycle | Cluster 10: Ciliated cells - Ion channel activity | Cluster 13: Syncytiotrophoblasts - Placental remodeling & endocrine func. | Cluster 14: Adipose tissue - Angiogenesis | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 1 | 0 | 1 | [
"Ovary Serous Cystadenocarcinoma"
] | [] | [
"Ovary Serous Cystadenocarcinoma"
] | 477 | 4 |
ENSG00000030066 | NUP160 | Nucleoporin 160 | [
"Q12769"
] | 11 | 47778087-47848555 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"FLJ22583",
"KIAA0197"
] | [
"Disease related genes",
"Essential proteins",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted intracellular proteins",
"Transporters"
] | [
"mRNA transport",
"Protein transport",
"Translocation",
"Transport"
] | [] | [
"Disease variant"
] | [] | [] | [] | [] | null | null | null | 38 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 55: Non-specific - Transcription | Cluster 24: Non-specific - Unknown function | Cluster 102: Non-specific - Mixed function | Cluster 61: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 2 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 478 | 8 |
ENSG00000030110 | BAK1 | BCL2 antagonist/killer 1 | [
"Q16611"
] | 6 | 33572547-33580293 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB005029"
] | [
"BAK",
"BCL2L7",
"CDN1"
] | [
"Predicted membrane proteins",
"Transporters"
] | [
"Apoptosis",
"Host-virus interaction"
] | [] | [] | [] | [] | [] | [] | null | Enhanced | null | 35 | null | null | Cluster 25: Non-specific - Unknown function | Cluster 43: Hindbrain - Mixed function | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 45: Colonocytes & Enterocytes - Gastrointestinal absorption & barrier | Cluster 5: Spleen - Immune response | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 2 | 1 | [] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 479 | 9 |
ENSG00000030304 | MUSK | Muscle associated receptor tyrosine kinase | [
"O15146"
] | 9 | 110668779-110806558 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Potential drug targets",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Differentiation"
] | [
"Developmental protein",
"Kinase",
"Muscle protein",
"Receptor",
"Transferase",
"Tyrosine-protein kinase"
] | [
"Congenital myasthenic syndrome",
"Disease variant"
] | [] | [] | [] | [] | null | null | null | 9 | null | null | null | Cluster 46: Brainstem - Mixed function | Cluster 33: Sarcoma - Muscle contraction | Cluster 46: Skeletal myocytes - Muscle structure & formation | Cluster 52: Non-specific - Cellular respiration | Tissue enhanced | Detected in some | null | Cancer enriched | Detected in single | 8 | Not detected | Not detected | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 480 | 9 |
ENSG00000030582 | GRN | Granulin precursor | [
"P28799"
] | 17 | 44345246-44353106 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA008763",
"CAB019394",
"HPA028747"
] | [
"CLN11",
"PCDGF",
"PGRN"
] | [
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [] | [
"Cytokine"
] | [
"Neurodegeneration",
"Neuronal ceroid lipofuscinosis"
] | [
"Lysosomes"
] | [
"Endosomes"
] | [
"Secreted to blood"
] | [
"Cytokine"
] | Enhanced | Uncertain | null | 233 | null | null | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 20: Macrophages & Microglia - Immune response | Cluster 27: Breast cancer - Unknown function | Cluster 72: Macrophages - Phagocytosis & lysosomal degradation | Cluster 11: Esophagus - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in all | 6 | 0 | 0 | 0 | [] | [] | [] | 482 | 8 |
ENSG00000031003 | FAM13B | Family with sequence similarity 13 member B | [
"Q9NYF5"
] | 5 | 137937960-138051961 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA036525",
"HPA041819",
"HPA071936"
] | [
"ARHGAP49",
"C5orf5",
"FAM13B1",
"KHCHP",
"N61"
] | [
"Predicted intracellular proteins"
] | [] | [
"GTPase activation"
] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | Uncertain | null | 4 | null | null | Cluster 24: Non-specific - Transcription | Cluster 34: Non-specific - Mixed function | Cluster 22: Non-specific - mRNA splicing & Cell cycle | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 61: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 1 | 2 | 0 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 483 | 3 |
ENSG00000031081 | ARHGAP31 | Rho GTPase activating protein 31 | [
"Q2M1Z3"
] | 3 | 119294383-119420714 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA036380"
] | [
"CDGAP"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [] | [
"GTPase activation"
] | [] | [] | [] | [] | [] | null | Approved | null | 5 | null | null | Cluster 13: Non-specific - Mitochondria | Cluster 19: Astrocytes - Mixed function | Cluster 55: Lymphoma - Immune response | Cluster 12: Endothelial cells - Angiogenesis & vascular homeostasis | Cluster 14: Adipose tissue - Angiogenesis | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 1 | 2 | 0 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 484 | 9 |
ENSG00000031698 | SARS1 | Seryl-tRNA synthetase 1 | [
"P49591"
] | 1 | 109213918-109238182 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA016939",
"HPA064668"
] | [
"SARS",
"SERS"
] | [
"Disease related genes",
"Enzymes",
"Essential proteins",
"Human disease related genes",
"Metabolic proteins",
"Plasma proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Protein biosynthesis",
"Transcription",
"Transcription regulation"
] | [
"Aminoacyl-tRNA synthetase",
"DNA-binding",
"Ligase"
] | [
"Disease variant",
"Epilepsy",
"Intellectual disability"
] | [
"Cytosol"
] | [] | [] | [] | Enhanced | Approved | null | 28 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 14: Neurons - Synaptic function | Cluster 13: Non-specific - Mixed function | Cluster 17: Non-specific - RNA processing | Cluster 70: Non-specific - Protein processing | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 2 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 486 | 2 |
ENSG00000031823 | RANBP3 | RAN binding protein 3 | [
"Q9H6Z4"
] | 19 | 5916139-5978142 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA043375",
"HPA043389"
] | [] | [
"Cancer-related genes",
"Predicted intracellular proteins"
] | [
"Protein transport",
"Transport"
] | [] | [
"Cancer-related genes"
] | [
"Nucleoplasm"
] | [] | [] | [] | Enhanced | Enhanced | null | 13 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 45: Non-specific - Mixed function | Cluster 23: Non-specific - Transcription | Cluster 53: Late primary spermatocytes - Meiotic division & transition | Cluster 74: Non-specific - Signal transduction | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 0 | 0 | 0 | [] | [] | [] | 487 | 1 |
ENSG00000032219 | ARID4A | AT-rich interaction domain 4A | [
"P29374"
] | 14 | 58298504-58373887 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA048899",
"HPA075572"
] | [
"RBBP1",
"RBP-1",
"RBP1"
] | [
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Differentiation",
"Spermatogenesis",
"Transcription",
"Transcription regulation"
] | [
"Chromatin regulator",
"DNA-binding"
] | [] | [
"Nucleoplasm"
] | [
"Plasma membrane"
] | [] | [] | Supported | null | null | 33 | null | null | Cluster 35: Neutrophils - Protein binding | Cluster 31: Non-specific - Transcription | Cluster 30: Non-specific - Gene expression regulation | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 44: Bone marrow - Nuclear processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 2 | 2 | [
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | [
"Ovary Serous Cystadenocarcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | 488 | 8 |
ENSG00000032389 | EIPR1 | EARP complex and GARP complex interacting protein 1 | [
"Q53HC9"
] | 2 | 3188925-3377830 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA031231",
"HPA031232",
"HPA031233",
"HPA031234"
] | [
"EIPR-1",
"TSSC1"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nucleoplasm",
"Nucleoli"
] | [
"Intermediate filaments"
] | [] | [] | Supported | Approved | null | 37 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 14: Neurons - Synaptic function | Cluster 6: Leukemia - Signal transduction | Cluster 7: Non-specific - Transcription | Cluster 10: Brain - Synaptic signal transduction | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Glioblastoma Multiforme",
"Lung Squamous Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Glioblastoma Multiforme",
"Liver Hepatocellular Carcinoma",
"Lung Squamous Cell Carcinoma"
] | 489 | 5 |
ENSG00000032742 | IFT88 | Intraflagellar transport 88 | [
"Q13099"
] | 13 | 20567138-20691444 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA078625"
] | [
"D13S1056E",
"hTg737",
"MGC26259",
"Tg737",
"TTC10"
] | [
"Predicted intracellular proteins",
"Transporters"
] | [
"Cilium biogenesis/degradation"
] | [] | [] | [
"Microtubules",
"Primary cilium",
"End piece"
] | [
"Cytokinetic bridge",
"Mitotic spindle",
"Centriolar satellite",
"Basal body",
"Connecting piece",
"Mid piece",
"Principal piece"
] | [] | [] | Approved | null | null | 49 | Yes | null | Cluster 14: Non-specific - Unknown function | Cluster 46: Brainstem - Mixed function | Cluster 19: Non-specific - Unknown function | Cluster 34: Ciliated cells - Cilia assembly & function | Cluster 48: Ciliated tissues - Cilium organization | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 1 | 2 | 0 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 491 | 1 |
ENSG00000033011 | ALG1 | ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase | [
"Q9BT22"
] | 16 | 5033702-5087379 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA060392"
] | [
"CDG1K",
"HMAT1",
"HMT-1",
"Mat-1"
] | [
"Disease related genes",
"Enzymes",
"Essential proteins",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [
"Glycosyltransferase",
"Transferase"
] | [
"Congenital disorder of glycosylation",
"Disease variant"
] | [
"Endoplasmic reticulum"
] | [
"Nucleoli fibrillar center"
] | [] | [] | Approved | Approved | null | 2 | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 17: Choroid plexus - Cilium | Cluster 54: Non-specific - Transcription | Cluster 79: Photoreceptor cells - Phototransduction | Cluster 1: Choroid plexus - Transmembrane transport | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 492 | 8 |
ENSG00000033030 | ZCCHC8 | Zinc finger CCHC-type containing 8 | [
"Q6NZY4"
] | 12 | 122471599-122501073 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA037483",
"HPA037484"
] | [
"DKFZp434E2220"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"mRNA processing",
"mRNA splicing"
] | [] | [
"Disease variant"
] | [
"Nucleoplasm"
] | [] | [] | [] | Enhanced | Supported | null | 65 | null | null | Cluster 24: Non-specific - Transcription | Cluster 4: Non-specific - mRNA splicing & Cell cycle | Cluster 38: Non-specific - Transcription | Cluster 37: Neutrophil progenitors - Granulopoiesis | Cluster 15: Bone marrow - Innate immune response | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 493 | 6 |
ENSG00000033050 | ABCF2 | ATP binding cassette subfamily F member 2 | [
"Q9UG63"
] | 7 | 151211484-151227205 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA020091",
"CAB020682",
"HPA021815",
"HPA030388"
] | [
"ABC28",
"EST133090",
"HUSSY-18",
"M-ABC1"
] | [
"Predicted intracellular proteins",
"Transporters"
] | [] | [] | [] | [
"Cytosol"
] | [] | [] | [] | Enhanced | Approved | null | 17 | null | null | Cluster 13: Non-specific - Mitochondria | Cluster 52: Neurons & Synapses - Synaptic function | Cluster 39: Non-specific - Transcription | Cluster 98: Neurons - Neurotransmission & signaling | Cluster 25: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Group enriched | Detected in some | 6 | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [] | [
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma"
] | 494 | 6 |
ENSG00000033100 | CHPF2 | Chondroitin polymerizing factor 2 | [
"Q9P2E5"
] | 7 | 151232483-151240979 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"HPA020992"
] | [
"ChSy-3",
"CSGlcA-T",
"KIAA1402"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [] | [
"Transferase"
] | [] | [
"Nucleoplasm",
"Cytosol"
] | [] | [
"Intracellular and membrane"
] | [
"Enzyme"
] | Approved | Approved | null | 1 | null | null | Cluster 29: Non-specific - Unknown function | Cluster 32: Cerebral cortex - Mixed function | Cluster 39: Non-specific - Transcription | Cluster 60: Cardiomyocytes - Cardiac muscle contraction & structure | Cluster 70: Non-specific - Protein processing | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 4 | 2 | 3 | [
"Pancreatic Adenocarcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | 495 | 5 |
ENSG00000033122 | LRRC7 | Leucine rich repeat containing 7 | [] | 1 | 69567922-70151945 | Evidence at protein level | Evidence at protein level | null | null | [
"HPA005625"
] | [
"densin-180",
"KIAA1365"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Plasma membrane",
"Cytosol"
] | [
"Nucleoplasm",
"Centrosome"
] | [] | [] | Supported | null | null | 8 | null | null | null | Cluster 33: Neurons - Mixed function | Cluster 47: Leukemia - Hemostasis | Cluster 35: Neurons - Synaptic function & neurogenesis | Cluster 73: Brain - Neuronal signaling | Tissue enhanced | Detected in some | null | Cancer enhanced | Detected in some | null | Cancer enhanced | Detected in single | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 496 | 1 |
ENSG00000033170 | FUT8 | Fucosyltransferase 8 | [
"Q9BYC5"
] | 14 | 65410592-65744121 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB017129",
"HPA043410"
] | [] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [
"Glycosyltransferase",
"Transferase"
] | [
"Congenital disorder of glycosylation",
"Disease variant"
] | [
"Golgi apparatus"
] | [
"Nucleoplasm",
"Cytosol"
] | [] | [] | Approved | Enhanced | null | 37 | null | null | Cluster 24: Non-specific - Transcription | Cluster 11: White matter - Signal transduction | Cluster 72: Neuronal - Signal transduction | Cluster 38: Secretory epithelial cells - Exocrine secretion | Cluster 3: Oligodendrocytes - Myelination | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in many | null | 2 | 0 | 2 | [] | [
"Glioblastoma Multiforme",
"Kidney Chromophobe"
] | [
"Glioblastoma Multiforme",
"Kidney Chromophobe"
] | 497 | 3 |
ENSG00000033327 | GAB2 | GRB2 associated binding protein 2 | [
"Q9UQC2"
] | 11 | 78215293-78418348 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA000271",
"HPA001368",
"CAB022159"
] | [
"KIAA0571"
] | [
"Predicted intracellular proteins",
"RAS pathway related proteins"
] | [] | [] | [] | [
"Plasma membrane"
] | [] | [] | [] | Supported | Enhanced | null | 37 | null | null | Cluster 35: Neutrophils - Protein binding | Cluster 11: White matter - Signal transduction | Cluster 47: Leukemia - Hemostasis | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 3: Oligodendrocytes - Myelination | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 3 | 2 | 2 | [
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma"
] | [
"Lung Squamous Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma",
"Lung Squamous Cell Carcinoma"
] | 499 | 4 |
ENSG00000033627 | ATP6V0A1 | ATPase H+ transporting V0 subunit a1 | [
"Q93050"
] | 17 | 42458844-42522582 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA022144"
] | [
"a1",
"ATP6N1",
"ATP6N1A",
"Stv1",
"Vph1",
"VPP1"
] | [
"Disease related genes",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Hydrogen ion transport",
"Ion transport",
"Transport"
] | [] | [
"Disease variant",
"Epilepsy",
"Intellectual disability"
] | [
"Golgi apparatus",
"Vesicles"
] | [
"Nuclear speckles",
"Cytosol"
] | [] | [] | Approved | Enhanced | null | 53 | null | null | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 14: Neurons - Synaptic function | Cluster 9: Skin cancer - Melanin biosynthesis | Cluster 79: Photoreceptor cells - Phototransduction | Cluster 46: Brain & retina - Neuronal signaling | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in many | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 500 | 4 |
ENSG00000033800 | PIAS1 | Protein inhibitor of activated STAT 1 | [
"O75925"
] | 15 | 68054309-68198603 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB012304",
"HPA073610"
] | [
"DDXBP1",
"GBP",
"GU/RH-II",
"ZMIZ3"
] | [
"Predicted intracellular proteins"
] | [
"Host-virus interaction",
"Transcription",
"Transcription regulation",
"Ubl conjugation pathway"
] | [
"DNA-binding",
"Transferase"
] | [] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Uncertain | Supported | null | 116 | null | null | Cluster 21: Neutrophils - Unknown function | Cluster 31: Non-specific - Transcription | Cluster 58: Non-specific - Nuclear processes | Cluster 37: Neutrophil progenitors - Granulopoiesis | Cluster 61: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 1 | 2 | 0 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 501 | 1 |
ENSG00000034053 | APBA2 | Amyloid beta precursor protein binding family A member 2 | [
"Q99767"
] | 15 | 28884483-29118315 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB037065",
"HPA058796",
"HPA070376"
] | [
"D15S1518E",
"HsT16821",
"LIN-10",
"MGC:14091",
"MINT2",
"X11L"
] | [
"Predicted intracellular proteins",
"Transporters"
] | [
"Protein transport",
"Transport"
] | [] | [] | [
"Golgi apparatus"
] | [] | [] | [] | Enhanced | Uncertain | null | 13 | null | null | Cluster 43: Non-specific - Transcription & Translation | Cluster 15: Non-specific - Transcription | Cluster 17: Neuroblastoma - Neuronal signaling | Cluster 102: Non-specific - Mixed function | Cluster 27: Cerebellum - Synaptic function | Tissue enriched | Detected in many | 8 | Cancer enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in some | null | Immune cell enhanced | Detected in some | null | 3 | 0 | 3 | [
"Glioblastoma Multiforme",
"Liver Hepatocellular Carcinoma",
"Rectum Adenocarcinoma"
] | [] | [
"Glioblastoma Multiforme",
"Liver Hepatocellular Carcinoma",
"Rectum Adenocarcinoma"
] | 503 | 6 |
ENSG00000034152 | MAP2K3 | Mitogen-activated protein kinase kinase 3 | [
"P46734"
] | 17 | 21284672-21315232 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB018548"
] | [
"MAPKK3",
"MEK3",
"MKK3",
"PRKMK3"
] | [
"Disease related genes",
"Enzymes",
"Potential drug targets",
"Predicted intracellular proteins"
] | [] | [
"Kinase",
"Serine/threonine-protein kinase",
"Transferase",
"Tyrosine-protein kinase"
] | [
"Disease variant"
] | [
"Nucleoplasm",
"Cytosol"
] | [] | [] | [] | Approved | Approved | null | 31 | null | null | Cluster 37: Monocytes & Neutrophils - Innate immune response | Cluster 42: Choroid plexus - Mitochondria | Cluster 64: Connective tissue cells - ECM organization | Cluster 31: Neutrophils - Chemotaxis & Apoptosis | Cluster 15: Bone marrow - Innate immune response | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Pancreatic Adenocarcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | 504 | 5 |
ENSG00000034239 | CLXN | Calaxin | [
"Q9HAE3"
] | 8 | 48710789-48735311 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"HPA023527"
] | [
"EFCAB1",
"FLJ11767",
"ODAD5"
] | [
"Predicted intracellular proteins"
] | [] | [] | [
"Ciliopathy",
"Disease variant",
"Kartagener syndrome",
"Primary ciliary dyskinesia"
] | [
"Mid piece",
"Principal piece"
] | [
"Nucleoplasm"
] | [] | [] | Approved | Enhanced | null | null | null | null | null | Cluster 3: Choroid plexus - Cilium | Cluster 10: Ciliated cells - Ion channel activity | Cluster 33: Early spermatids - Spermiogenesis: Cap phase | Cluster 48: Ciliated tissues - Cilium organization | Group enriched | Detected in many | 4 | Cancer enhanced | Detected in some | null | Cancer enhanced | Detected in many | null | Group enriched | Detected in some | 4 | Immune cell enhanced | Detected in single | null | 1 | 0 | 1 | [] | [
"Pancreatic Adenocarcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | 505 | 4 |
ENSG00000034510 | TMSB10 | Thymosin beta 10 | [
"P63313"
] | 2 | 84905656-84906671 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"TB10"
] | [
"Essential proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [
"Actin-binding"
] | [] | [] | [] | [] | [] | null | null | null | 14 | null | null | Cluster 29: Non-specific - Unknown function | Cluster 51: Neurons - Mixed function | Cluster 37: Non-specific - mRNA processing | Cluster 15: Non-specific - Protein processing | Cluster 49: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 506 | 3 |
ENSG00000034677 | RNF19A | Ring finger protein 19A, RBR E3 ubiquitin protein ligase | [
"Q9NV58"
] | 8 | 100257060-100336218 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB011455",
"HPA023652"
] | [
"DKFZp566B1346",
"dorfin",
"RNF19"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Ubl conjugation pathway"
] | [
"Transferase"
] | [] | [] | [] | [] | [] | null | Approved | null | 6 | null | null | Cluster 24: Non-specific - Transcription | Cluster 39: Astrocytes - Mixed function | Cluster 51: Myeloma - Immunoglobulins | Cluster 51: Secretory epithelial cells - Mixed function | Cluster 39: Testis - Nuclear processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 4 | 0 | 4 | [
"Kidney Renal Clear Cell Carcinoma",
"Rectum Adenocarcinoma"
] | [
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma",
"Rectum Adenocarcinoma"
] | 508 | 9 |
ENSG00000034693 | PEX3 | Peroxisomal biogenesis factor 3 | [
"P56589"
] | 6 | 143450805-143490616 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA042830",
"HPA058006"
] | [] | [
"Disease related genes",
"Human disease related genes",
"Potential drug targets",
"Predicted membrane proteins",
"Transporters"
] | [
"Peroxisome biogenesis"
] | [] | [
"Disease variant",
"Peroxisome biogenesis disorder",
"Zellweger syndrome"
] | [
"Nucleoplasm",
"Peroxisomes"
] | [] | [] | [] | Approved | Supported | null | 36 | null | null | Cluster 43: Non-specific - Transcription & Translation | Cluster 31: Non-specific - Transcription | Cluster 28: Non-specific - Nuclear processes | Cluster 32: Endothelial cells - Angiogenesis & vascular immunity | Cluster 76: Non-specific - Metabolism | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma",
"Rectum Adenocarcinoma"
] | [
"Breast Invasive Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Rectum Adenocarcinoma"
] | 509 | 5 |
ENSG00000034713 | GABARAPL2 | GABA type A receptor associated protein like 2 | [
"P60520"
] | 16 | 75566375-75577881 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA036726"
] | [
"ATG8",
"ATG8C",
"GATE-16",
"GATE16",
"GEF2"
] | [
"Predicted intracellular proteins"
] | [
"Autophagy",
"Protein transport",
"Transport"
] | [] | [] | [
"Nucleoplasm",
"Cytosol"
] | [
"Nuclear bodies"
] | [] | [] | Uncertain | Uncertain | null | 136 | null | null | Cluster 21: Neutrophils - Unknown function | Cluster 27: Non-specific - Mixed function | Cluster 68: Non-specific - Cell cycle regulation | Cluster 97: Non-specific - Cellular respiration | Cluster 3: Oligodendrocytes - Myelination | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Stomach Adenocarcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Stomach Adenocarcinoma"
] | 510 | 3 |
ENSG00000034971 | MYOC | Myocilin | [
"Q99972"
] | 1 | 171635417-171652688 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA027364"
] | [
"GLC1A",
"JOAG1",
"TIGR"
] | [
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Predicted secreted proteins"
] | [] | [] | [
"Disease variant",
"Glaucoma"
] | [] | [] | [
"Secreted to extracellular matrix"
] | [
"No annotated function"
] | null | Uncertain | null | 6 | null | null | null | Cluster 30: White matter - Myelination | Cluster 5: Rhabdoid - Unknown function | Cluster 108: Fibroblasts - ECM organization | Cluster 12: Smooth muscle tissue - ECM organization | Tissue enhanced | Detected in many | null | Cancer enriched | Detected in some | 45 | Cancer enriched | Detected in some | 9 | Group enriched | Detected in some | 6 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 511 | 1 |
ENSG00000035141 | FAM136A | Family with sequence similarity 136 member A | [
"Q96C01"
] | 2 | 70295976-70302067 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA030103",
"HPA030104"
] | [
"FLJ14668"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Mitochondria"
] | [] | [] | [] | Approved | Enhanced | null | 22 | null | null | Cluster 32: Basophils - Transcription | Cluster 24: Neurons - Mixed function | Cluster 26: Non-specific - Mitochondria & RNA binding | Cluster 44: Plasma cells - Antibody production & secretion | Cluster 38: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 2 | 1 | [] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 513 | 2 |
ENSG00000035403 | VCL | Vinculin | [
"P18206"
] | 10 | 73995193-74121363 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA002131",
"CAB002453",
"HPA063777"
] | [] | [
"Disease related genes",
"Essential proteins",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Cell adhesion"
] | [
"Actin-binding"
] | [
"Cardiomyopathy",
"Disease variant"
] | [
"Focal adhesion sites"
] | [] | [] | [] | Enhanced | Enhanced | null | 44 | null | null | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 42: Choroid plexus - Mitochondria | Cluster 52: Non-specific - Mitochondria | Cluster 51: Secretory epithelial cells - Mixed function | Cluster 12: Smooth muscle tissue - ECM organization | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enriched | Detected in all | 4 | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 514 | 1 |
ENSG00000035499 | DEPDC1B | DEP domain containing 1B | [
"Q8WUY9"
] | 5 | 60596912-60700190 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA038255",
"HPA072558"
] | [
"BRCC3",
"XTP1"
] | [
"Predicted intracellular proteins"
] | [] | [
"GTPase activation"
] | [] | [
"Golgi apparatus"
] | [
"Nucleoplasm",
"Cytosol"
] | [] | [] | Approved | Approved | null | 15 | null | Yes | Cluster 5: Non-specific - Cell proliferation | Cluster 30: White matter - Myelination | Cluster 15: Kidney cancer - Membrane components | Cluster 27: Non-specific - Cell proliferation | Cluster 59: Lymphoid tissue & Bone marrow - Cell proliferation | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in some | null | 5 | 6 | 2 | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 515 | 1 |
ENSG00000035664 | DAPK2 | Death associated protein kinase 2 | [
"Q9UIK4"
] | 15 | 63907036-64072033 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA071581"
] | [
"DRP-1",
"MGC119312"
] | [
"Enzymes",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Apoptosis"
] | [
"Calmodulin-binding",
"Kinase",
"Serine/threonine-protein kinase",
"Transferase"
] | [] | [
"Golgi apparatus",
"Vesicles"
] | [] | [] | [] | Supported | null | null | 1 | null | null | Cluster 36: Eosinophils - Protein ubiquitination | Cluster 11: White matter - Signal transduction | Cluster 57: Stomach & Colon cancer - Digestion | Cluster 36: Skeletal myocytes - Muscle excitation & contraction | Cluster 62: Skeletal muscle - Muscle contraction | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cancer enriched | Detected in all | 14 | Cell type enhanced | Detected in many | null | Group enriched | Detected in many | 15 | 1 | 0 | 1 | [
"Lung Adenocarcinoma"
] | [] | [
"Lung Adenocarcinoma"
] | 516 | 2 |
ENSG00000035681 | NSMAF | Neutral sphingomyelinase activation associated factor | [
"Q92636"
] | 8 | 58583508-58659853 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA023067",
"HPA023148",
"HPA023151"
] | [
"FAN",
"GRAMD5"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nucleoli"
] | [] | [] | [] | Approved | Uncertain | null | 16 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 27: Non-specific - Mixed function | Cluster 40: Non-specific - Unknown function | Cluster 31: Neutrophils - Chemotaxis & Apoptosis | Cluster 49: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 517 | 6 |
ENSG00000035862 | TIMP2 | TIMP metallopeptidase inhibitor 2 | [
"P16035"
] | 17 | 78852977-78925387 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"CAB010203"
] | [
"CSC-21K"
] | [
"Cancer-related genes",
"Candidate cardiovascular disease genes",
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [] | [
"Metalloenzyme inhibitor",
"Metalloprotease inhibitor",
"Protease inhibitor"
] | [
"Cancer-related genes"
] | [] | [] | [
"Secreted to extracellular matrix"
] | [
"Enzyme inhibitor"
] | null | Approved | null | 20 | null | null | Cluster 7: Non-specific - Innate immune response | Cluster 27: Non-specific - Mixed function | Cluster 64: Connective tissue cells - ECM organization | Cluster 108: Fibroblasts - ECM organization | Cluster 75: Ovary - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 1 | 0 | 1 | [] | [
"Stomach Adenocarcinoma"
] | [
"Stomach Adenocarcinoma"
] | 520 | 1 |
ENSG00000035928 | RFC1 | Replication factor C subunit 1 | [
"P35251"
] | 4 | 39287456-39366375 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB009520",
"HPA046116",
"HPA069306"
] | [
"A1",
"MHCBFB",
"PO-GA",
"RFC140"
] | [
"Disease related genes",
"Essential proteins",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"DNA replication",
"Transcription",
"Transcription regulation"
] | [
"Activator",
"DNA-binding"
] | [
"Neuropathy"
] | [
"Nucleoplasm"
] | [] | [] | [] | Enhanced | Supported | null | 50 | null | null | Cluster 24: Non-specific - Transcription | Cluster 28: Oligodendrocytes - Mixed function | Cluster 22: Non-specific - mRNA splicing & Cell cycle | Cluster 66: Erythroid cells - Erythroid differentiation and maturation | Cluster 61: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Chromophobe"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma"
] | 521 | 9 |
ENSG00000036054 | TBC1D23 | TBC1 domain family member 23 | [
"Q9NUY8"
] | 3 | 100260992-100325251 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA038151",
"HPA038152"
] | [
"FLJ11046"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [
"Developmental protein"
] | [
"Disease variant"
] | [
"Golgi apparatus"
] | [] | [] | [] | Enhanced | Approved | null | 10 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 55: Non-specific - Transcription | Cluster 5: Rhabdoid - Unknown function | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 76: Non-specific - Metabolism | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 4 | 0 | 4 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Chromophobe",
"Ovary Serous Cystadenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Ovary Serous Cystadenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 522 | 2 |
ENSG00000036257 | CUL3 | Cullin 3 | [
"Q13618"
] | 2 | 224470150-224585397 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB002678",
"HPA072059"
] | [] | [
"Disease related genes",
"Essential proteins",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Cell cycle",
"Cell division",
"Cilium biogenesis/degradation",
"ER-Golgi transport",
"Mitosis",
"Transport",
"Ubl conjugation pathway"
] | [] | [
"Autism spectrum disorder",
"Disease variant",
"Epilepsy",
"Intellectual disability"
] | [
"Nucleoplasm"
] | [
"Microtubules",
"Cytokinetic bridge"
] | [] | [] | Supported | Supported | null | 858 | Yes | null | Cluster 21: Neutrophils - Unknown function | Cluster 31: Non-specific - Transcription | Cluster 26: Non-specific - Mitochondria & RNA binding | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 39: Testis - Nuclear processes | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 1 | 2 | 0 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 523 | 7 |
ENSG00000036448 | MYOM2 | Myomesin 2 | [
"P54296"
] | 8 | 2045046-2165552 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA001765",
"HPA005953"
] | [] | [
"Predicted intracellular proteins"
] | [] | [
"Muscle protein"
] | [] | [
"Mitochondria"
] | [] | [] | [] | Approved | Enhanced | null | 12 | null | null | null | Cluster 53: Neurons - Mixed function | Cluster 51: Myeloma - Immunoglobulins | Cluster 55: Myocytes - Oxidative muscle function | Cluster 41: Striated muscle - Muscle contraction | Group enriched | Detected in some | 6 | Group enriched | Detected in some | 19 | Not detected | Not detected | null | Group enriched | Detected in many | 5 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 524 | 2 |
ENSG00000036473 | OTC | Ornithine transcarbamylase | [
"P00480"
] | X | 38352586-38421446 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA000243",
"HPA000570"
] | [
"OTC1",
"OTCase",
"OTCD"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Plasma proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Amino-acid biosynthesis",
"Arginine biosynthesis",
"Urea cycle"
] | [
"Transferase"
] | [
"Disease variant"
] | [
"Mitochondria"
] | [] | [] | [] | Supported | Enhanced | null | 2 | null | null | null | null | Cluster 57: Stomach & Colon cancer - Digestion | Cluster 1: Enterocytes - Absorption and Digestion | Cluster 45: Liver - Metabolism & Coagulation | Group enriched | Detected in some | 122 | Cancer enhanced | Detected in single | null | Cancer enriched | Detected in some | 18 | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Rectum Adenocarcinoma"
] | [
"Rectum Adenocarcinoma"
] | 525 | 3 |
ENSG00000036530 | CYP46A1 | Cytochrome P450 family 46 subfamily A member 1 | [
"Q9Y6A2"
] | 14 | 99684298-99727301 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"CYP46"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [
"Cholesterol metabolism",
"Lipid metabolism",
"Steroid metabolism",
"Sterol metabolism"
] | [
"Monooxygenase",
"Oxidoreductase"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | Cluster 44: Plasmacytoid DCs - Plasma membrane proteins | Cluster 33: Neurons - Mixed function | Cluster 14: Myeloid leukemia - Innate immune response | Cluster 35: Neurons - Synaptic function & neurogenesis | Cluster 78: Brain - Neuronal signaling | Tissue enriched | Detected in many | 10 | Not detected | Not detected | null | Cancer enriched | Detected in some | 7 | Cell type enhanced | Detected in many | null | Immune cell enriched | Detected in single | 23 | 1 | 0 | 1 | [] | [
"Kidney Chromophobe"
] | [
"Kidney Chromophobe"
] | 526 | 8 |
ENSG00000036549 | ZZZ3 | Zinc finger ZZ-type containing 3 | [
"Q8IYH5"
] | 1 | 77562416-77683419 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA053663",
"HPA054913",
"HPA066197"
] | [
"ATAC1",
"DKFZP564I052"
] | [
"Predicted intracellular proteins"
] | [
"Transcription",
"Transcription regulation"
] | [
"DNA-binding"
] | [] | [
"Nucleoplasm",
"Nucleoli",
"Nucleoli rim"
] | [] | [] | [] | Enhanced | Uncertain | null | 24 | No | No | Cluster 3: Non-specific - Nuclear processes | Cluster 28: Oligodendrocytes - Mixed function | Cluster 37: Non-specific - mRNA processing | Cluster 7: Non-specific - Transcription | Cluster 61: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in many | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 527 | 6 |
ENSG00000036565 | SLC18A1 | Solute carrier family 18 member A1 | [
"P54219"
] | 8 | 20144855-20183206 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA006877",
"HPA063797"
] | [
"CGAT",
"VAT1",
"VMAT1"
] | [
"FDA approved drug targets",
"Metabolic proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Neurotransmitter transport",
"Transport"
] | [] | [
"FDA approved drug targets"
] | [] | [] | [] | [] | null | Enhanced | null | 1 | null | null | Cluster 37: Monocytes & Neutrophils - Innate immune response | Cluster 41: Monoamines - Neurotransmitter signalling | Cluster 17: Neuroblastoma - Neuronal signaling | Cluster 96: Enteroendocrine cells - Neuropeptide signaling | Cluster 4: Adrenal gland - Steroid metabolism | Tissue enriched | Detected in some | 8 | Cancer enriched | Detected in some | 10 | Cancer enhanced | Detected in some | null | Group enriched | Detected in some | 19 | Immune cell enhanced | Detected in single | null | 0 | 0 | 0 | [] | [] | [] | 528 | 6 |
ENSG00000036672 | USP2 | Ubiquitin specific peptidase 2 | [
"O75604"
] | 11 | 119355215-119381711 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA006777",
"HPA007222"
] | [
"UBP41"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [
"Biological rhythms",
"Cell cycle",
"Myogenesis",
"Ubl conjugation pathway"
] | [
"Hydrolase",
"Protease",
"Thiol protease"
] | [] | [
"Cytosol"
] | [
"Plasma membrane"
] | [] | [] | Supported | Approved | null | 120 | null | null | null | Cluster 16: Non-specific - Transcription | Cluster 46: Lymphoma - Humoral immune response | Cluster 73: Late spermatids - Spermiogenesis: Maturation | Cluster 25: Non-specific - Basic cellular processes | Tissue enhanced | Detected in all | null | Cancer enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Group enriched | Detected in many | 5 | Not detected in immune cells | Not detected | null | 1 | 2 | 0 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 529 | 5 |
ENSG00000036828 | CASR | Calcium sensing receptor | [
"P41180"
] | 3 | 122183668-122291629 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA039686",
"HPA050335"
] | [
"FHH",
"GPRC2A",
"HHC",
"HHC1",
"NSHPT"
] | [
"Disease related genes",
"FDA approved drug targets",
"G-protein coupled receptors",
"Human disease related genes",
"Plasma proteins",
"Predicted membrane proteins",
"Transporters"
] | [] | [
"G-protein coupled receptor",
"Receptor",
"Transducer"
] | [
"Disease variant",
"Epilepsy",
"FDA approved drug targets"
] | [] | [] | [] | [] | null | Enhanced | null | 9 | null | null | null | Cluster 9: Non-specific - Receptor signaling | Cluster 16: Thyroid cancer - Neuronal signaling | Cluster 50: Renal epithelial cells - Ion transport and pH regulation | Cluster 69: Parathyroid gland - Mixed function | Tissue enriched | Detected in some | 29 | Cancer enriched | Detected in single | 10 | Cancer enhanced | Detected in some | null | Group enriched | Detected in some | 4 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 530 | 6 |
ENSG00000037042 | TUBG2 | Tubulin gamma 2 | [
"Q9NRH3"
] | 17 | 42659284-42667006 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"CAB011495",
"HPA043012"
] | [] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Centriolar satellite",
"Principal piece"
] | [] | [] | [] | Supported | Approved | null | 19 | null | null | Cluster 30: Non-specific - DNA binding | Cluster 52: Neurons & Synapses - Synaptic function | Cluster 51: Myeloma - Immunoglobulins | Cluster 94: Gonadal somatic cells - Mixed function | Cluster 36: Brain & Liver - Signaling | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 531 | 1 |
ENSG00000037241 | RPL26L1 | Ribosomal protein L26 like 1 | [
"Q9UNX3"
] | 5 | 172958729-172969771 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA030449"
] | [
"RPL26P1"
] | [
"Essential proteins",
"Predicted intracellular proteins",
"Ribosomal proteins"
] | [] | [
"Ribonucleoprotein",
"Ribosomal protein"
] | [] | [
"Endoplasmic reticulum",
"Cytosol"
] | [
"Nucleoli"
] | [] | [] | Approved | Approved | null | 155 | null | null | Cluster 13: Non-specific - Mitochondria | Cluster 14: Neurons - Synaptic function | Cluster 22: Non-specific - mRNA splicing & Cell cycle | Cluster 53: Late primary spermatocytes - Meiotic division & transition | Cluster 56: Ciliated tissues - Cilium organization | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 4 | 2 | 3 | [] | [
"Bladder Urothelial Carcinoma",
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Bladder Urothelial Carcinoma",
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 532 | 8 |
ENSG00000037280 | FLT4 | Fms related receptor tyrosine kinase 4 | [
"P35916"
] | 5 | 180601506-180649624 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA067906",
"HPA074389"
] | [
"PCL",
"VEGFR-3",
"VEGFR3"
] | [
"Cancer-related genes",
"Disease related genes",
"Enzymes",
"FDA approved drug targets",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Predicted secreted proteins",
"RAS pathway related proteins",
"Transporters"
] | [
"Angiogenesis"
] | [
"Kinase",
"Receptor",
"Transferase",
"Tyrosine-protein kinase"
] | [
"Cancer-related genes",
"Disease variant",
"FDA approved drug targets"
] | [
"Cytosol"
] | [
"Plasma membrane",
"Centrosome"
] | [
"Secreted to blood"
] | [
"Receptor"
] | Supported | Approved | null | 24 | null | null | Cluster 1: T-cells - Unknown function | Cluster 47: Endothelial cells - Vasculature | Cluster 54: Non-specific - Transcription | Cluster 32: Endothelial cells - Angiogenesis & vascular immunity | Cluster 14: Adipose tissue - Angiogenesis | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in some | null | Immune cell enriched | Detected in single | 4 | 3 | 2 | 2 | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Lung Squamous Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Squamous Cell Carcinoma"
] | 533 | 5 |
ENSG00000037637 | FBXO42 | F-box protein 42 | [
"Q6P3S6"
] | 1 | 16246840-16352480 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA025071"
] | [
"Fbx42",
"KIAA1332"
] | [
"Predicted intracellular proteins"
] | [
"Ubl conjugation pathway"
] | [] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | Approved | null | 29 | null | null | Cluster 10: Non-specific - Membrane trafficking | Cluster 10: Cerebellum - Nucleic acid binding | Cluster 37: Non-specific - mRNA processing | Cluster 7: Non-specific - Transcription | Cluster 24: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Rectum Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Rectum Adenocarcinoma"
] | 535 | 4 |
ENSG00000037749 | MFAP3 | Microfibril associated protein 3 | [
"P55082"
] | 5 | 154038959-154220478 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA015883",
"HPA049198"
] | [] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [] | [] | [
"Golgi apparatus"
] | [
"Nucleoplasm"
] | [] | [] | Approved | Approved | null | 1 | null | null | Cluster 41: Basophils - Unknown function | Cluster 5: Non-specific - Mixed function | Cluster 22: Non-specific - mRNA splicing & Cell cycle | Cluster 32: Endothelial cells - Angiogenesis & vascular immunity | Cluster 28: Liver & Adrenal gland - Secretion | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 536 | 4 |
ENSG00000037757 | MRI1 | Methylthioribose-1-phosphate isomerase 1 | [
"Q9BV20"
] | 19 | 13764522-13774282 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA042744",
"CAB045988"
] | [
"MGC3207",
"MRDI",
"mtnA",
"Ypr118w"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [
"Amino-acid biosynthesis",
"Methionine biosynthesis"
] | [
"Isomerase"
] | [] | [
"Nucleoplasm",
"Cytosol"
] | [
"Nucleoli fibrillar center"
] | [] | [] | Supported | Approved | null | 8 | No | No | Cluster 13: Non-specific - Mitochondria | Cluster 30: White matter - Myelination | Cluster 23: Non-specific - Transcription | Cluster 98: Neurons - Neurotransmission & signaling | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in many | null | 3 | 0 | 3 | [
"Breast Invasive Carcinoma",
"Rectum Adenocarcinoma"
] | [
"Skin Cutaneous Melanoma"
] | [
"Breast Invasive Carcinoma",
"Rectum Adenocarcinoma",
"Skin Cutaneous Melanoma"
] | 537 | 3 |
ENSG00000037965 | HOXC8 | Homeobox C8 | [
"P31273"
] | 12 | 54008985-54012769 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA028911",
"CAB037020"
] | [
"HOX3",
"HOX3A"
] | [
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"Developmental protein",
"DNA-binding"
] | [] | [
"Nucleoplasm",
"Microtubules"
] | [] | [] | [] | Approved | Uncertain | null | 82 | null | null | null | null | Cluster 64: Connective tissue cells - ECM organization | Cluster 62: Smooth muscle cells - Muscle contraction | Cluster 63: Non-specific - Basic cellular processes | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 2 | 2 | 1 | [] | [
"Colon Adenocarcinoma",
"Glioblastoma Multiforme"
] | [
"Colon Adenocarcinoma",
"Glioblastoma Multiforme"
] | 539 | 6 |
ENSG00000038002 | AGA | Aspartylglucosaminidase | [
"P20933"
] | 4 | 177430774-177442437 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA031415",
"HPA031417"
] | [
"ASRG"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Plasma proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [] | [
"Hydrolase",
"Protease"
] | [
"Disease variant"
] | [] | [] | [
"Intracellular and membrane"
] | [
"Enzyme"
] | null | Enhanced | null | 9 | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 50: Non-specific - Nucleic acid binding | Cluster 63: Non-specific - Protein processing | Cluster 78: Plasma cells - Antibody production & ER-stress response | Cluster 22: Epididymis - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 540 | 4 |
ENSG00000038210 | PI4K2B | Phosphatidylinositol 4-kinase type 2 beta | [
"Q8TCG2"
] | 4 | 25160663-25279204 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA004099"
] | [
"FLJ11105",
"PI4KIIB",
"PIK42B"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [
"Lipid metabolism"
] | [
"Kinase",
"Transferase"
] | [] | [
"Cytosol"
] | [] | [] | [] | Supported | Enhanced | null | 16 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 50: Non-specific - Nucleic acid binding | Cluster 22: Non-specific - mRNA splicing & Cell cycle | Cluster 37: Neutrophil progenitors - Granulopoiesis | Cluster 77: Intestine - Digestion | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in many | null | 4 | 0 | 4 | [
"Colon Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Chromophobe",
"Thyroid Carcinoma"
] | [
"Colon Adenocarcinoma",
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Thyroid Carcinoma"
] | 541 | 1 |
ENSG00000038219 | BOD1L1 | Biorientation of chromosomes in cell division 1 like 1 | [
"Q8NFC6"
] | 4 | 13568738-13627725 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA036943",
"HPA037362",
"HPA041290"
] | [
"BOD1L",
"FAM44A",
"FLJ33215",
"KIAA1327"
] | [
"Predicted intracellular proteins"
] | [
"DNA damage",
"DNA repair"
] | [] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | Approved | null | 18 | null | null | Cluster 21: Neutrophils - Unknown function | Cluster 16: Non-specific - Transcription | Cluster 22: Non-specific - mRNA splicing & Cell cycle | Cluster 48: Neutrophils - Phagocytosis & degranulation | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Immune cell enhanced | Detected in many | null | 1 | 2 | 0 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 542 | 6 |
ENSG00000038274 | MAT2B | Methionine adenosyltransferase 2B | [
"Q9NZL9"
] | 5 | 163503114-163519558 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA037721",
"HPA037722"
] | [
"MATIIbeta",
"SDR23E1"
] | [
"Metabolic proteins",
"Predicted intracellular proteins"
] | [
"One-carbon metabolism"
] | [] | [] | [
"Plasma membrane"
] | [] | [] | [] | Approved | Uncertain | null | 12 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 14: Neurons - Synaptic function | Cluster 22: Non-specific - mRNA splicing & Cell cycle | Cluster 92: NK-cells & T-cells - Adaptive immunity: Cytotoxicity | Cluster 76: Non-specific - Metabolism | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma",
"Rectum Adenocarcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Rectum Adenocarcinoma"
] | 543 | 3 |
ENSG00000038295 | TLL1 | Tolloid like 1 | [
"O43897"
] | 4 | 165873237-166104457 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA060767"
] | [] | [
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [
"Differentiation"
] | [
"Developmental protein",
"Hydrolase",
"Metalloprotease",
"Protease"
] | [
"Atrial septal defect",
"Disease variant"
] | [
"Vesicles"
] | [] | [
"Secreted to extracellular matrix"
] | [
"Developmental protein"
] | Approved | null | null | null | null | null | null | Cluster 35: Non-specific - DNA binding | Cluster 15: Kidney cancer - Membrane components | Cluster 12: Endothelial cells - Angiogenesis & vascular homeostasis | Cluster 43: Placenta - Pregnancy hormone signaling | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cancer enhanced | Detected in some | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 544 | 2 |
ENSG00000038358 | EDC4 | Enhancer of mRNA decapping 4 | [
"Q6P2E9"
] | 16 | 67873052-67884499 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA041164",
"HPA043038"
] | [
"Ge-1",
"HEDLS",
"RCD-8"
] | [
"Essential proteins",
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Cytoplasmic bodies"
] | [
"Nucleoplasm"
] | [] | [] | Supported | Supported | null | 46 | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 34: Non-specific - Mixed function | Cluster 68: Non-specific - Cell cycle regulation | Cluster 22: Non-specific - Basic cellular functions | Cluster 1: Choroid plexus - Transmembrane transport | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 3 | 0 | 3 | [
"Glioblastoma Multiforme",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 545 | 5 |
ENSG00000038382 | TRIO | Trio Rho guanine nucleotide exchange factor | [
"O75962"
] | 5 | 14143342-14532128 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA008157",
"HPA064664"
] | [
"ARHGEF23"
] | [
"Cancer-related genes",
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Potential drug targets",
"Predicted intracellular proteins"
] | [] | [
"Guanine-nucleotide releasing factor",
"Kinase",
"Serine/threonine-protein kinase",
"Transferase"
] | [
"Cancer-related genes",
"Disease variant",
"Intellectual disability"
] | [
"Cytosol"
] | [
"Vesicles",
"Plasma membrane",
"Primary cilium",
"Primary cilium tip",
"Basal body"
] | [] | [] | Supported | Supported | null | 13 | No | No | null | Cluster 40: Astrocytes - Astrocyte-neuron interactions | Cluster 29: Non-specific - Unknown function | Cluster 51: Secretory epithelial cells - Mixed function | Cluster 24: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Immune cell enhanced | Detected in some | null | 5 | 0 | 5 | [
"Rectum Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Thyroid Carcinoma",
"Uterine Corpus Endometrial Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Rectum Adenocarcinoma",
"Thyroid Carcinoma",
"Uterine Corpus Endometrial Carcinoma"
] | 546 | 3 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.